(Q75203923)

English

Anti-B4 blocked ricin post chemotherapy in patients with chronic lymphocytic leukemia--long-term follow-up of a monoclonal antibody-based approach to residual disease

scientific article published on 01 October 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Anti-B4 blocked ricin post chemotherapy in patients with chronic lymphocytic leukemia--long-term follow-up of a monoclonal antibody-based approach to residual disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

Apostolia Maria Tsimberidou

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

author name string

Francis J Giles

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Hagop M Kantarjian

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Michael J Keating

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Susan M O'Brien

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

1719-1725

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116706

21 January 2018

Effect of cell arrangement and interstitial volume fraction on the diffusivity of monoclonal antibodies in tissue

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116706

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116706

21 January 2018

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116706

21 January 2018

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116706

21 January 2018

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116706

21 January 2018

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116706

21 January 2018

Progress in CLL, chemotherapy, antibodies and transplantation

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000116706

21 January 2018

Identifiers

10.1080/1042819031000116706

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692524%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q75203923&oldid=2098368362"